In-vitro diagnostics market in India, which has hugely been driven by the increasing number of lifestyle diseases, inclining preventive healthcare practices, mounting disposable incomes, government’s initiatives and improving healthcare infrastructure, registered revenues of USD ~ million in FY’2013. With the advent of new varieties of diagnostic tests incorporating latest technology, the revenues increased by 25.8% compared to FY’2012, where the total revenues were USD ~ million. In-vitro diagnostics market in India is subject to a gamut of different factors, such as people with diabetes, heart, kidney and other infectious and lifestyle diseases, and the overall disposable incomes in the country, which play an important role in determining the revenues from various diagnostic segments. Immunochemistry was the largest contributing category in terms of revenue, having recorded sales of USD ~ million in fiscal year 2013, while biochemistry, hematology and microbiology also contributed a significant share to the overall revenues. The India in-vitro diagnostics market has grown at a CAGR of 19.4% from USD 303.2 million in FY’2007 to USD ~ million in FY’2013.

The in-vitro diagnostics market in India is comprised of various manufacturers that specialize in the development and production of diagnostic products in different segments. Along with the presence of leading diagnostic companies in the organized sector, market in India is also driven by the revenues of a huge number of manufacturers in the unorganized segment. Roche was the market leader in the overall IVD market India, while also dominating the immunochemistry and biochemistry segments in fiscal year 2013. In addition to the prevalence of several players in the organized segment, the market is also driven by the imports of numerous diagnostic products from China and other countriesIn-vitro diagnostics market in India has showcased several emerging trends over the past few years. Some of the most definitive of these trends has been the advent of decentralized testing, mounting automation in laboratories, increasing consolidation and preference for early detection of diseases. Several pathological labs have resorted to invest heftily, and have been adopting fully automated systems for diseases diagnosis. In light of this, the accuracy of test results has increased, while the turnaround times have declined significantly. Additionally, the growth of portable diagnostics devices has propelled the market for point of care testing in India.

The market for in-vitro diagnostics in India is changing at a brisk rate. Technological advancements, demand of diagnostic tests from an ever growing base of disease-ridden population, and people suffering from lifestyle diseases, as well as the transition of diagnostic product manufacturers from the unorganized to the organized segment have been significantly changing the market. Revenues from the in-vitro diagnostics market in India are expected to expand to USD ~ million in FY’2018, growing with a CAGR of ~% from FY’2013 to FY’2018.

KEY TOPICS COVERED IN THE REPORT

- The market size of the India in-vitro diagnostics market.- The market size of the India immunochemistry market.- The market size of the India immunochemistry reagents and instruments.- The market size of the India biochemistry market.- The market size of the India hematology market.- The market size of the India microbiology market.- Market segmentation of the India in-vitro diagnostics market on the basis of type of tests, contribution from reagents and instruments, and contribution from urban and rural areas. - Market segmentation of the India Immunochemistry market on the basis of contribution from reagents and instruments, ELISA kits and rapid tests, and the market segmentation of immunochemistry instruments and reagents by types of tests and end use. - Market segmentation of the India biochemistry market on the basis of contribution from reagents and instruments.- Market segmentation of the India hematology market on the basis of contribution from reagents and instruments.- Market segmentation of the India microbiology market on the basis of contribution from reagents and instruments.- Market segmentation of the India blood gas and electrolyte market on the basis of contribution from reagents and instruments.- Market segmentation of the India molecular diagnostics market on the basis of contribution from reagents and instruments.- Market segmentation of the India urinalysis market on the basis of contribution from reagents and instruments.- Market segmentation of the India coagulation market on the basis of contribution from reagents and instruments.- Trends and Development in the India in-vitro diagnostics market.- Competitive landscape and detailed company profiles of the major manufacturers of diagnostics products in India- Future outlook and projections of the India in-vitro diagnostics market.

Figure 1: India In-Vitro Diagnostics Market Size on the Basis of Revenues in USD Million, FY'2007-FY'2013Figure 2: India In-Vitro Diagnostics Market Segmentation on the Basis of Revenues from Instruments and Reagents in Percentage, FY'2010-FY'2013Figure 3: India In-Vitro Diagnostics Market Segmentation on the Basis of Revenues from Urban and Rural Areas in Percentage, FY'2013Figure 4: India In-Vitro Diagnostics Market Segmentation on the Basis of Revenues from Different Tests in Percentage, FY'2007-FY'2013Figure 5: India Immunochemistry Market Size on the Basis of Revenues in USD Million, FY'2007-FY'2013Figure 6: India Immunochemistry Market Segmentation on the Basis of Revenues from Reagents and Instruments, ELISA Kits and Rapid Tests in Percentage, FY'2007-FY'2013Figure 7: India Immunochemistry Instruments and Reagents Market Size on the Basis of Revenues in USD Million, FY'2007-FY'2013Figure 8: India Immunochemistry Instruments and Reagents Market Segmentation on the Basis of Revenues from Instruments and Reagents in Percentage, FY'2007-FY'2013Figure 9: India Immunochemistry Instruments and Reagents Market Segmentation on the Basis of Revenues from Different Types of Instruments and Reagents in Percentage, FY'2007-FY'2013Figure 10: India Immunochemistry Reagents Market Segmentation on the Basis of Revenues from End Use in Different Types of Diagnostic Tests in Percentage, FY'2007-FY'2013Figure 11: India Biochemistry Market Size on the Basis of Revenues in USD Million, FY'2007-FY'2013Figure 12: India Biochemistry Market Segmentation on the Basis of Revenues from Reagents and Instruments in Percentage, FY'2007-FY'2013Figure 13: India Biochemistry Instruments Market Segmentation on the Basis of Revenues from Different Types of Analyzers in Percentage, FY'2011-FY'2013Figure 14: Market Share of Major Players on the Basis of Revenues in the Biochemistry Market in India in Percentage, FY'2013Figure 15: India Hematology Market Size on the Basis of Revenues in USD Million, FY'2007-FY'2013Figure 16: India Hematology Market Segmentation on the Basis of Revenues from Reagents and Instruments in Percentage, FY'2007-FY'2013Figure 17: India Hematology Instruments Market Segmentation on the Basis of Revenues from Different Type of Instruments in Percentage, FY'2009-FY'2012Figure 18: India Microbiology Market Size on the Basis of Revenues in USD Million, FY'2007-FY'2013Figure 19: India Microbiology Market Segmentation on the Basis of Revenues from Reagents and Instruments in Percentage, FY'2008-FY'2013Figure 20: India Blood Gas and Electrolyte Market Size on the Basis of Revenues in USD Million, FY'2007-FY'2013Figure 21: India Blood Gas and Electrolyte Market Segmentation on the Basis of Revenues from Reagents and Analyzers in Percentage, FY'2007-FY'2013Figure 22: India Blood Gas and Electrolyte Analyzers Market Segmentation on the Basis of Revenues from Different Types of Analyzers in Percentage, FY'2009-FY'2013Figure 23: Market Share of Major Players on the Basis of Revenues in the Blood Gas and Electrolyte Market in Percentage, FY'2013Figure 24: India Molecular Diagnostics Market Size on the Basis of Revenues in USD Million, FY'2007-FY2013Figure 25: India Molecular Diagnostics Market Segmentation on the Basis of Revenues from Reagents and Instruments in Percentage, FY'2007-FY'2013Figure 26: India Urinalysis Market Size on the Basis of Revenues in USD Million, FY'2007-FY'2013Figure 27: India Urinalysis Market Segmentation on the Basis of Revenues from Reagents and Instruments in Percentage, FY'2007-FY'2013Figure 28: India Coagulation Diagnostics Market Size on the Basis of Revenues in USD Million, FY'2007-FY'2013Figure 29: India Coagulation Diagnostics Market Segmentation on the Basis of Revenues from Reagents and Instruments in Percentage, FY'2007-FY'2013Figure 30: Market Share of Major Players on the Basis of Revenues in the India In-Vitro Diagnostics Market in Percentage, FY'2013Figure 31: India In-Vitro Diagnostics Market Future Projections on the Basis of Revenues in USD Million, FY'2014-FY'2018Figure 32: Population in India in Million, FY'2007-FY'2018Figure 33: Personal Disposable Incomes in India in USD Million, FY'2007-FY'2018Figure 34: Consumer Expenditure on Healthcare and Medical Services in India in USD Million, FY'2007-FY'2018Figure 35: Government Expenditure on Health Care in India in USD Million, FY'2007-FY'2018Figure 36: Foreign Direct Investment in Healthcare Sector in India in USD Million, FY'2008-FY'2013Figure 37: Private Equity Investments in Healthcare Sector in India in USD Million, 2009-2012

LIST OF TABLES

Table 1: India In-Vitro Diagnostics Market Segmentation on the Basis of Revenues from Instruments and Reagents in USD Million, FY'2010-FY'2013Table 2: India In-Vitro Diagnostics Market Segmentation on the Basis of Revenues from Different Tests in USD Million, FY'2007-FY'2013Table 3: India Immunochemistry Market Segmentation on the Basis of Revenues from Reagents and Instruments, ELISA Kits and Rapid Tests in USD Million, FY'2007-FY'2013Table 4: India Immunochemistry Instruments and Reagents Market Segmentation on the Basis of Revenues from Instruments and Reagents in USD Million, FY'2007-FY'2013Table 5: Market Share of Major Players on the Basis of Revenues in the Immunochemistry Market in India in Percentage, FY'2013Table 6: India Biochemistry Market Segmentation on the Basis of Revenues from Reagents and Instruments in USD Million, FY'2007-FY'2013Table 7: India Hematology Market Segmentation on the Basis of Revenues from Reagents and Instruments in USD Million, FY'2007-FY'2013Table 8: Major Players in Hematology Instruments and Reagents Market in IndiaTable 9: India Microbiology Market Segmentation on the Basis of Revenues from Reagents and Instruments in USD Million, FY'2008-FY'2013Table 10: Market Share of Major Players on the Basis of Revenues in the Hematology Reagents Market in Percentage, FY'2013Table 11: India Blood Gas and Electrolyte Market Segmentation on the Basis of Revenues from Reagents and Analyzers in USD Million, FY'2007-FY'2013Table 12: Major Players in the India Blood Gas and Electrolyte MarketTable 13: India Molecular Diagnostics Market Segmentation on the Basis of Revenues from Reagents and Instruments in USD Million, FY'2007-FY'2013Table 14: India Urinalysis Market Segmentation on the Basis of Revenues from Reagents and Instruments in USD Million, FY'2007-FY'2013Table 15: India Urinalysis Analyzers Market Segmentation on the Basis of Sales Quantity of Different Analyzers in Units and Percentage USD Million, FY'2012Table 16: India Coagulation Diagnostics Market Segmentation on the Basis of Revenues from Reagents and Instruments in USD Million, FY'2007-FY'2013Table 17: Company Profile of Major Players (Roche Diagnostic, Abbott Laboratories, Transasia Biomedicals, Siemens Healthcare, Beckman Coulter, Becton and Dickinson and Sysmex) in India In-Vitro Diagnostic MarketTable 18: Cause and Effect Relationship Analysis between Industry Factors and Expected In-Vitro Diagnostics Market Prospects in IndiaTable 19: India Population Segmentation on the Basis of People Residing in Urban and Rural Areas in Million, FY'2007-FY'2013Table 20: Correlation Matrix of the India In-Vitro Diagnostics MarketTable 21: Regression Coefficients Output

This new report from VPGMarketResearch.com reviews operating characteristics and features of major automated and semi-automated high-, medium-, and low-volume/POC in vitro diagnostic systems within the ...

This new report from VPGMarketResearch.com provides assessments of emerging in vitro diagnostic technologies and their potential applications within the following market segments: Blood Typing, Grouping, ...

This Kalorama Information report, The Worldwide Market for In Vitro Diagnostic Tests, has been updated for two decades in ten editions, keeping readers informed about developments in all areas of IVD, ...